美股市场个股详情
DCPH Deciphera Pharmaceuticals
- 25.280
- +10.630+72.56%
收盘价 04/29 16:00 (美东)
- 25.200
- -0.080-0.32%
盘后 19:45 (美东)
20.79亿总市值-11039市盈率TTM
25.400最高价25.165最低价5072.45万股成交量25.200今开14.650昨收12.75亿成交额118.78%换手率亏损市盈率(静)8222.60万总股本25.40052周最高5.92市净率10.80亿流通值9.90052周最低--股息TTM4270.49万流通股71.110历史最高--股息率TTM1.60%振幅6.510历史最低25.135平均价1股每手
关于Deciphera Pharmaceuticals公司
Deciphera Pharmaceuticals, Inc.是一家生物制药公司，致力于发现、开发和为癌症患者提供重要的新药治疗。该公司设计了一种候选药物DCC-2618，用于抑制驱动胃肠道间质瘤、晚期系统性肥大细胞增多症、胶质瘤和其他实体瘤等癌症的突变或扩增的KIT和PDGFRa激酶的全谱。
公司介绍
公司代码DCPH
公司名称Deciphera Pharmaceuticals
上市日期2017/09/28
发行价格17.00
成立日期2003
CEOMr. Steven L. Hoerter
所属市场纳斯达克
员工数量355
证券类型海外普通股
年结日12-31
公司地址200 Smith Street
城市Waltham
省份马萨诸塞州
国家美国
邮编02451
电话1-781-209-6400
董事高管
- 姓名
- 职务
- 年薪
- Steven L. Hoerter
- Director, President and Chief Executive Officer
- 601.07万
- Dashyant Dhanak
- Executive Vice President and Chief Scientific Officer
- --
- Thomas P. Kelly
- Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer
- 203.08万
- Daniel C. Martin
- Senior Vice President and Chief Commercial Officer
- 157.89万
- Dr. Matthew L. Sherman, M.D.
- Executive Vice President and Chief Medical Officer
- 212.89万
- Jama Pitman
- Senior Vice President, Regulatory, Quality and Portfolio Management
- --
- Ron Squarer
- Chairman of the Board
- 40.33万
- Dennis L. Walsh
- Independent Director
- 38.61万
- Dr. James A. Bristol, PhD
- Independent Director
- 41.48万
- Dr. Edward J. Benz, Jr,M.D.
- Independent Director
- 39.61万
- Patricia L. Allen
- Independent Director
- 39.86万
- John R. Martin
- Independent Director
- 38.86万
- Frank S. Friedman
- Independent Director
- 38.23万
- Dr. Susan L. Kelley, M.D.
- Independent Director
- 39.61万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅